| Old Articles: <Older 11941-11950 Newer> |
 |
The Motley Fool January 25, 2006 Rich Smith |
Foolish Forecast: Columbia Calling Even if sales rise a bit, as expected, investors need to watch those inventory levels closely; make sure the company isn't swamping itself in unwanted goods that it will need to unload at cut-rate prices in the future.  |
The Motley Fool January 25, 2006 Brian Gorman |
PAREXEL Recovers The clinical research services company is in better shape, but it still has progress to make. Investors should approach the company with some caution.  |
The Motley Fool January 25, 2006 Rick Aristotle Munarriz |
Comfort Food to Go Shares of Cracker Barrel's parent company CBRL Group opened 12% higher -- and kept inching upward -- after the company announced that it was interviewing financial advisors in a move that may be a prelude to a bidding block.  |
The Motley Fool January 25, 2006 Jeremy MacNealy |
IFF Still Lacks Flavor International Flavors & Fragrances continues to struggle with declining sales and margins. Investors, take note.  |
The Motley Fool January 25, 2006 Alyce Lomax |
New York Times in a Bind Although there were some bright spots, it's apparent that New York Times is still ensnared in the challenges of an industry that is being forced to evolve. Investors, beware.  |
The Motley Fool January 25, 2006 Rich Smith |
Foolish Forecast: Sybase at Bat Sybase faces plenty of competition in the database market and as it head into tomorrow's earnings report for fourth-quarter and full-year 2005, the company looks set to end the year not with a bang, but with a whimper.  |
The Motley Fool January 25, 2006 Stephen D. Simpson |
In Case of Guidance, Break Corning? A big pre-earnings run-up left the stock primed for disappointment. In fact, you have to make some really robust growth assumptions on the cash flow side to get close to fair value at today's prices.  |
The Motley Fool January 25, 2006 Stephen D. Simpson |
Abbott Wins No matter what Boston Scientific does with Guidant, Abbott looks like a winner. This stock might not offer a rocket ride the way smaller biotechs and med-tech companies do, but at today's prices, at least you won't have to worry about a fiery re-entry.  |
The Motley Fool January 25, 2006 Rich Smith |
Foolish Forecast: Caterpillar Purrs The secret to Cat's net profit success: margins. Despite high energy and raw materials costs, Cat has managed to keep its gross margin deterioration to a minimum. Investors, take note.  |
The Motley Fool January 25, 2006 Kelvin Taylor |
The Rise and Fall of Synaptics The growth outlook isn't promising as the company tries to rebound from losing Apple's business. Those who bought Synaptics stock thinking it would return to the highs of 2005 might be in for a disappointment.  |
| <Older 11941-11950 Newer> Return to current articles. |